ALK rearrangements are commonly identified in lung adenocarcinoma; LCNEC with ALK rearrangements is exceedingly rare and often associath-grade pathology, advanced-stage presentation, and poor prognosis (Zheng et al., 2018; Shaw et al., 2013). The gene discussed is ALK; the disease is lung adenocarcinoma.